Senseonics vs. Novo Nordisk: Which Diabetes Stock is a Better Buy?

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXMPEB280W7_M.jpg

Diabetes is rising at an alarming rate in the West, accelerated by the remote lifestyles and work-from-home routines. As a result, pharmaceutical companies have been experimenting with innovative drugs to cure and manage the ailment. Many companies have reported promising results from their clinical trials, indicating that a diabetes treatment drug might soon be available in the market.

The size of the global diabetes drug market is projected to hit $78.30 billion by 2026, growing at a 6.1% CAGR.

Continue reading on StockNews